Importantly, levels of IGF-1 in the kidney decrease significantly following MI, whereas exogenous IGF-1 supplementation improves renal function (Cui and He, 2022), highlighting its crucial role in modulating the “heart–kidney axis.” This evidence concerns the gene IGF1 and myocardial infarction.